54
Participants
Start Date
December 1, 2020
Primary Completion Date
March 14, 2024
Study Completion Date
March 14, 2024
Nicotinamide Riboside + Pterostilbene
It will be administered a total of 1000 mg/day of NR and 200 mg/day of Ptero in a regimen of 2 capsules of Basis™ (each capsule 250 mg of NR and 50 mg of Ptero) 2 times a day by mouth for 2 weeks before surgery and 6 weeks after surgery. Each intake has to be apart from each other by, at least, 6 hours of interval.
Placebo
The correspondent placebo will be administered in a regimen of 2 capsules 2 times a day by mouth for 2 weeks before surgery and 6 weeks after surgery. Each intake has to be apart from each other by, at least, 6 hours of interval.
Mayo Clinic, Rochester
Lead Sponsor
Collaborators (1)
Elysium Health
INDUSTRY
Mayo Clinic
OTHER